64 related articles for article (PubMed ID: 8106098)
1. Frequency of IFN beta 1 gene loss in 47 primary human gliomas.
Sugawa N; Ekstrand AJ; Ueda S; Collins VP
Noshuyo Byori; 1993; 10(2):161-3. PubMed ID: 8106098
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 9 deletion mapping reveals interferon alpha and interferon beta-1 gene deletions in human glial tumors.
James CD; He J; Carlbom E; Nordenskjold M; Cavenee WK; Collins VP
Cancer Res; 1991 Mar; 51(6):1684-8. PubMed ID: 1998958
[TBL] [Abstract][Full Text] [Related]
3. Clonal genomic alterations in glioma malignancy stages.
James CD; Carlbom E; Dumanski JP; Hansen M; Nordenskjold M; Collins VP; Cavenee WK
Cancer Res; 1988 Oct; 48(19):5546-51. PubMed ID: 2901288
[TBL] [Abstract][Full Text] [Related]
4. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
Jin W; Xu X; Yang T; Hua Z
Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines.
Roversi G; Pfundt R; Moroni RF; Magnani I; van Reijmersdal S; Pollo B; Straatman H; Larizza L; Schoenmakers EF
Oncogene; 2006 Mar; 25(10):1571-83. PubMed ID: 16247447
[TBL] [Abstract][Full Text] [Related]
6. Deletion of alpha-, beta-, and omega-interferon genes in malignant cells from children with acute lymphocytic leukemia.
Einhorn S; Grandér D; Björk O; Bröndum-Nielsen K; Söderhäll S
Cancer Res; 1990 Dec; 50(24):7781-5. PubMed ID: 1701354
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity at 11p15 in malignant glioma.
Sonoda Y; Iizuka M; Yasuda J; Makino R; Ono T; Kayama T; Yoshimoto T; Sekiya T
Cancer Res; 1995 May; 55(10):2166-8. PubMed ID: 7743518
[TBL] [Abstract][Full Text] [Related]
8. A common region of homozygous deletion in malignant human gliomas lies between the IFN alpha/omega gene cluster and the D9S171 locus.
Ichimura K; Schmidt EE; Yamaguchi N; James CD; Collins VP
Cancer Res; 1994 Jun; 54(12):3127-30. PubMed ID: 8205529
[TBL] [Abstract][Full Text] [Related]
9. PTEN gene mutations are seen in high-grade but not in low-grade gliomas.
Rasheed BK; Stenzel TT; McLendon RE; Parsons R; Friedman AH; Friedman HS; Bigner DD; Bigner SH
Cancer Res; 1997 Oct; 57(19):4187-90. PubMed ID: 9331072
[TBL] [Abstract][Full Text] [Related]
10. Gliomas.
Collins VP
Cancer Surv; 1998; 32():37-51. PubMed ID: 10489622
[TBL] [Abstract][Full Text] [Related]
11. Fine mapping of a region of common deletion on chromosome arm 10p in human glioma.
Voesten AM; Bijleveld EH; Westerveld A; Hulsebos TJ
Genes Chromosomes Cancer; 1997 Oct; 20(2):167-72. PubMed ID: 9331567
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
Yamaguchi T; Toguchida J; Wadayama B; Kanoe H; Nakayama T; Ishizaki K; Ikenaga M; Kotoura Y; Sasaki MS
Anticancer Res; 1996; 16(4A):2009-15. PubMed ID: 8712735
[TBL] [Abstract][Full Text] [Related]
13. Amplification at 12q13-14 in human malignant gliomas is frequently accompanied by loss of heterozygosity at loci proximal and distal to the amplification site.
Reifenberger G; Reifenberger J; Ichimura K; Collins VP
Cancer Res; 1995 Feb; 55(4):731-4. PubMed ID: 7850781
[TBL] [Abstract][Full Text] [Related]
14. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
15. The reliability of the differential polymerase chain reaction compared to restriction fragment length polymorphism for the detection of gene loss in primary tumors.
Sugawa N; Ueda S
Cancer Lett; 1996 Feb; 99(2):139-46. PubMed ID: 8616817
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity of chromosome 10p in human gliomas.
Kimmelman AC; Ross DA; Liang BC
Genomics; 1996 Jun; 34(2):250-4. PubMed ID: 8661060
[TBL] [Abstract][Full Text] [Related]
17. Refined deletion mapping of the chromosome 19q glioma tumor suppressor gene to the D19S412-STD interval.
Rosenberg JE; Lisle DK; Burwick JA; Ueki K; von Deimling A; Mohrenweiser HW; Louis DN
Oncogene; 1996 Dec; 13(11):2483-5. PubMed ID: 8957092
[TBL] [Abstract][Full Text] [Related]
18. The putative tumor suppressor gene FHIT at 3p14.2 is rarely affected by loss of heterozygosity in primary human brain tumors.
Frank S; Müller J; Plaschke J; Hahn M; Hampl J; Hampl M; Pistorius S; Schackert G; Schackert HK
Cancer Res; 1997 Jul; 57(13):2638-41. PubMed ID: 9205070
[TBL] [Abstract][Full Text] [Related]
19. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
20. Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization.
Weber RG; Sabel M; Reifenberger J; Sommer C; Oberstrass J; Reifenberger G; Kiessling M; Cremer T
Oncogene; 1996 Sep; 13(5):983-94. PubMed ID: 8806688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
